RenalSense

RenalSense is at the forefront of medical equipment manufacturing, dedicated to revolutionizing real-time renal diagnostics. With a focus on innovation and patient care, RenalSense is committed to providing cutting-edge solutions that enhance critical care management. The company's pioneering product, Clarity RMS, is transforming ICU practices by continuously monitoring urine flow, enabling real-time assessment of renal function and facilitating the early detection and prevention of ICU-acquired Acute Kidney Injury (AKI). This advanced technology addresses a critical need in modern healthcare, offering the potential to improve patient outcomes and reduce healthcare costs.

RenalSense's Clarity RMS features an end-to-end, fully automated system designed to facilitate the early detection and prevention of ICU-acquired AKI. The system includes an electronic sensor that easily connects to a Foley catheter, reliably measuring fluctuations in urine flow. This data is transmitted in real-time to a console with embedded technology, displaying the information graphically and simultaneously updating the patient's electronic medical record (EMR). An intelligent alarm system alerts the medical team to any deviations from the pre-set standard for minimum urine output, ensuring timely intervention.

Located at Hamrpe 3, Har Hotzvim, P.O.B. 45397, Jerusalem, 9145101, IL, and with an additional office at 1309 Beacon St, suite300, Brookline, MA 02446, US, RenalSense is dedicated to advancing the field of nephrology and improving patient care through innovative medical devices. The company remains focused on expanding its reach and enhancing its offerings to better serve healthcare providers and patients worldwide. Soon, comprehensive information and further details will be completed with the support of the RenalSense management team.

To the RenalSense management team, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative solutions.